Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Wireless implant for brain-computer interface in people with tetraplegia from spinal cord injury

Official title: A Prospective, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of Implantable Wireless Brain-Computer Interface Systems in Patients With Tetraplegia

Run by BCIFlex Medical Technology Co., Ltd. · NCT07784088 · Data updated 2026-11-12

This trial tests a wireless brain-computer interface implanted in adults with tetraplegia to see if it is safe and if it can help restore some function.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment34 (estimated)
SponsorBCIFlex Medical Technology Co., Ltd.
Industry-sponsored
Locations1 site (Beijing)
StatusRecruiting
StartedJuly 15, 2026
Main results expectedJune 2027
Study endsJuly 2027
Registry record updatedAugust 25, 2026
Trial IDNCT07784088 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with cervical SCI (C2–C5) tetraplegia, ASIA A–B, stable for at least 6 months, and adequate cognitive function.

Probably not a fit

Individuals with additional complications such as syringomyelia, high surgical risk, active infection, or those with incompatible CNS devices may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates an implantable wireless brain-computer interface system in adults aged 18 to 65 with cervical spinal cord injury causing tetraplegia. Participants must have stable neurological condition, intact cognitive function, and limited elbow flexor strength, and must meet specific ASIA impairment criteria. The study will monitor safety and potential efficacy signals of the implanted device, with follow-up designed to assess device performance and any functional changes. No comparator is specified in the available details, and the trial is led by BCIFlex Medical Technology with collaboration from Beijing Tiantan Hospital in China.

Why it matters

Potential benefit: If successful, participants could experience improved interaction with external devices or assistive technologies via the implanted system.

How similar studies have gone: Previous studies in brain-computer interface research have demonstrated safety signals and functional gains in related populations, but this specific implant and approach are under investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years and ≤65 years, male or female;
* Tetraplegia due to C2-C5 cervical spinal cord injury, diagnosed per 2019 revised ISNCSCI of ASIA, injury grade A to B;
* Intact cognitive function, MoCA-BLIND score ≥19;
* Elbow flexor muscle strength ≤ Grade 3 by ISNCSCI;
* Neurological assessment confirms normal motor cortex function without significant organic or functional brain lesions;
* Tetraplegia diagnosed for ≥12 months, stable clinical status ≥6 months after standard treatment;
* Good compliance, voluntary participation; informed consent signed by subject or legal representative.

Exclusion Criteria:

* Syringomyelia, severe neuralgia or spasticity limiting training participation;
* Require tracheotomy, mechanical ventilation, nasogastric feeding to sustain vital functions;
* High surgical risk: active systemic infection, coagulation disorders, antithrombotic therapy users;
* Subjects implanted with CNS electrical stimulation medical devices;
* Unstable medical conditions, severe mental/cognitive disorders confounding endpoint assessment;
* Severe, unstable, uncontrolled complex regional pain syndrome;
* Autoimmune-induced spinal cord dysfunction/injury;
* History of stroke, multiple sclerosis, drug-resistant epilepsy, Alzheimer's Disease;
* Peripheral neuropathy;
* Pregnant/breastfeeding females, females planning pregnancy during trial;
* Require MRI examinations during device implantation period;
* Participated in other clinical trials within 1 month prior to enrollment;
* Investigator judges participation unsafe, or subject unlikely to complete protocol follow-up.

Where it's running

  • Beijing Tiantan Hospital, Capital Medical University
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.